Global Irritable Bowel Syndrome (IBS) Competitive Landscape Professional Research Report 2024
Research Summary
Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by a combination of symptoms, including abdominal pain, bloating, changes in bowel habits, and discomfort. IBS is considered a functional gastrointestinal disorder, meaning there is no structural abnormality or damage to the digestive tract. The exact cause of IBS is not well understood, but factors such as abnormalities in the gut-brain axis, hypersensitivity of the intestines, and changes in gut motility may contribute to its development. IBS can be categorized into different subtypes based on predominant symptoms, such as IBS with constipation (IBS-C), IBS with diarrhea (IBS-D), or mixed-type (alternating between constipation and diarrhea). Diagnosis is typically based on the presence of characteristic symptoms, and healthcare providers may recommend dietary changes, medications, and lifestyle modifications to manage symptoms. Although IBS can be a chronic condition, it does not lead to serious complications or increase the risk of other gastrointestinal diseases. Management strategies are focused on alleviating symptoms and improving the quality of life for individuals with IBS.
According to DIResearch's in-depth investigation and research, the global Irritable Bowel Syndrome (IBS) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Irritable Bowel Syndrome (IBS) include Bausch Health, Allergan, Takeda, Sucampo Pharmaceuticals (Mallinckrodt), Sebela Pharmaceuticals Inc, Astellas Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Irritable Bowel Syndrome (IBS). Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Irritable Bowel Syndrome (IBS) market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Irritable Bowel Syndrome (IBS) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Irritable Bowel Syndrome (IBS) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Irritable Bowel Syndrome (IBS) Include:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
Irritable Bowel Syndrome (IBS) Product Segment Include:
IBS-D Drug
IBS-C Drug
Others
Irritable Bowel Syndrome (IBS) Product Application Include:
Women
Men
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Irritable Bowel Syndrome (IBS) Industry PESTEL Analysis
Chapter 3: Global Irritable Bowel Syndrome (IBS) Industry Porter’s Five Forces Analysis
Chapter 4: Global Irritable Bowel Syndrome (IBS) Major Regional Market Size and Forecast Analysis
Chapter 5: Global Irritable Bowel Syndrome (IBS) Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Irritable Bowel Syndrome (IBS) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Irritable Bowel Syndrome (IBS) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Irritable Bowel Syndrome (IBS) Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Irritable Bowel Syndrome (IBS) Product by Type
- 1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 IBS-D Drug
- 1.2.3 IBS-C Drug
- 1.2.4 Others
- 1.3 Irritable Bowel Syndrome (IBS) Product by Application
- 1.3.1 Global Irritable Bowel Syndrome (IBS) Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Women
- 1.3.3 Men
- 1.4 Global Irritable Bowel Syndrome (IBS) Market Revenue Analysis (2019-2030)
- 1.5 Irritable Bowel Syndrome (IBS) Market Development Status and Trends
- 1.5.1 Irritable Bowel Syndrome (IBS) Industry Development Status Analysis
- 1.5.2 Irritable Bowel Syndrome (IBS) Industry Development Trends Analysis
- 2 Irritable Bowel Syndrome (IBS) Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Irritable Bowel Syndrome (IBS) Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Irritable Bowel Syndrome (IBS) Market Analysis by Regions
- 4.1 Irritable Bowel Syndrome (IBS) Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Irritable Bowel Syndrome (IBS) Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2025-2030)
- 5 Global Irritable Bowel Syndrome (IBS) Market Size by Type and Application
- 5.1 Global Irritable Bowel Syndrome (IBS) Market Size by Type
- 5.2 Global Irritable Bowel Syndrome (IBS) Market Size by Application
- 6 North America
- 6.1 North America Irritable Bowel Syndrome (IBS) Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type
- 6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Application
- 6.5 North America Irritable Bowel Syndrome (IBS) Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Irritable Bowel Syndrome (IBS) Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
- 7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
- 7.5 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Irritable Bowel Syndrome (IBS) Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Irritable Bowel Syndrome (IBS) Market Size by Type
- 8.4 China Irritable Bowel Syndrome (IBS) Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Irritable Bowel Syndrome (IBS) Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Irritable Bowel Syndrome (IBS) Market Size by Type
- 9.4 APAC (excl. China) Irritable Bowel Syndrome (IBS) Market Size by Application
- 9.5 APAC (excl. China) Irritable Bowel Syndrome (IBS) Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Irritable Bowel Syndrome (IBS) Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
- 10.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
- 10.5 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
- 11.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
- 11.5 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Irritable Bowel Syndrome (IBS) Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Irritable Bowel Syndrome (IBS) Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Irritable Bowel Syndrome (IBS) Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Bausch Health
- 13.1.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Bausch Health Irritable Bowel Syndrome (IBS) Product Portfolio
- 13.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Allergan
- 13.2.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Allergan Irritable Bowel Syndrome (IBS) Product Portfolio
- 13.2.3 Allergan Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Takeda
- 13.3.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Portfolio
- 13.3.3 Takeda Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Sucampo Pharmaceuticals (Mallinckrodt)
- 13.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product Portfolio
- 13.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Sebela Pharmaceuticals Inc
- 13.5.1 Sebela Pharmaceuticals Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product Portfolio
- 13.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Astellas Pharmaceuticals
- 13.6.1 Astellas Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Portfolio
- 13.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Irritable Bowel Syndrome (IBS) Industry Chain Analysis
- 14.2 Irritable Bowel Syndrome (IBS) Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Irritable Bowel Syndrome (IBS) Typical Downstream Customers
- 14.4 Irritable Bowel Syndrome (IBS) Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook